Open AccessA Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines
Author(s) -
Sang Soo Eom,
Wonyoung Choi,
Bang Wool Eom,
Sin Hye Park,
Young-Il Kim,
Young Il Kim,
Hong Man Yoon,
Jong Yeul Lee,
Chan Gyoo Kim,
Hark Kyun Kim,
Myeong–Cherl Kook,
Il Ju Choi,
Young Woo Kim,
Young Iee Park
Publication year - 2022
Publication title -
journal of gastric cancer/daehan wiam haghoeji
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.806
H-Index - 28
eISSN - 2093-5641
pISSN - 1598-1320
DOI - 10.5230/jgc.2022.22.e10
Subject(s) - guideline , medicine , grading (engineering) , evidence based medicine , intensive care medicine , cancer , perioperative , family medicine , medline , evidence based practice , scientific evidence , alternative medicine , surgery , pathology , philosophy , civil engineering , epistemology , political science , law , engineering
Countries differ in their treatment expertise and research results regarding gastric cancer; hence, treatment guidelines are diverse based on evidence and medical situations. A comprehensive and comparative review of each country's guidelines is imperative to understand the similarities and differences among countries. We reviewed and compared five gastric cancer treatment guidelines in terms of endoscopic, surgical, perioperative, and palliative systemic treatment based on evidence levels and recommendation grades, as well as the postoperative follow-up strategies for each guideline. The Korean, Chinese, and European guidelines provided evidence and grading of the recommendations. The United States guidelines suggested categories for evidence and consensus. The Japanese guidelines suggested evidence and recommendations only for systemic treatment. The Korean and Japanese guidelines described endoscopic treatment, surgery, and lymphadenectomy in detail. The Chinese, United States, and European guidelines more intensively considered perioperative chemotherapy. In particular, the indications for chemotherapy and the regimens recommended by each guideline differed slightly. Considering their medical situations, each guideline had some diversity in terms of adopting evidence, which resulted in heterogeneous recommendations. This review will help medical personnel to comprehensively understand the diversity in gastric cancer treatment guidelines for each country in terms of evidence and recommendations.